Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-10

Clinical Trial Update: Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates the combination of bexarotene, tretinoin, and chemotherapy in patients with stage III or stage IV non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bexarotene (Bexarotene)
  • Combination chemotherapy
  • TRETINOIN (TRETINOIN)

Snippet

Sponsor: Raghu Nandan, M.D., Inc | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN